| Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase G Kumar, P Parasuraman, SK Sharma, T Banerjee, K Karmodiya, ... Journal of medicinal chemistry 50 (11), 2665-2675, 2007 | 119 | 2007 |
| Formulation of nanotized curcumin and demonstration of its antimalarial efficacy A Ghosh, T Banerjee, S Bhandary, A Surolia International journal of nanomedicine, 5373-5387, 2014 | 47 | 2014 |
| SAR and pharmacophore models for the rhodanine inhibitors of Plasmodium falciparum enoyl‐acyl carrier protein reductase G Kumar, T Banerjee, N Kapoor, N Surolia, A Surolia IUBMB life 62 (3), 204-213, 2010 | 28 | 2010 |
| Apicoplast triose phosphate transporter (TPT) gene knockout is lethal for Plasmodium T Banerjee, DK Jaijyan, N Surolia, AP Singh, A Surolia Molecular and biochemical parasitology 186 (1), 44-50, 2012 | 24 | 2012 |
| Benzothiophene carboxamide derivatives as inhibitors of Plasmodium falciparum enoyl‐ACP reductase T Banerjee, SK Sharma, N Kapoor, V Dwivedi, N Surolia, A Surolia IUBMB life 63 (12), 1101-1110, 2011 | 24 | 2011 |
| An in silico scientific basis for LL‐37 as a therapeutic for Covid‐19 KB Lokhande, T Banerjee, KV Swamy, P Ghosh, M Deshpande Proteins: Structure, Function, and Bioinformatics 90 (5), 1029-1043, 2022 | 22 | 2022 |
| Epigallocatechin gallate is a slow-tight binding inhibitor of Enoyl-ACP Reductase from Plasmodium falciparum A Banerjee, T., Sharma, S. K., Surolia, N., Surolia BBRC 277, 1238-1242, 2008 | 19* | 2008 |
| Benzothiophene carboxamide derivatives as novel antimalarials T Banerjee, N Kapoor, N Surolia, A Surolia IUBMB life 63 (12), 1111-1115, 2011 | 17 | 2011 |
| Design, development, synthesis, and docking analysis of 2′‐substituted triclosan analogs as inhibitors for Plasmodium falciparum Enoyl‐ACP reductase N Kapoor, T Banerjee, P Babu, K Maity, N Surolia, A Surolia IUBMB life 61 (11), 1083-1091, 2009 | 17 | 2009 |
| 15‐deoxyspergualin hinders physical interaction between basic residues of transit peptide in PfENR and Hsp70‐1 T Banerjee, RR Singh, S Gupta, A Surolia, N Surolia IUBMB life 64 (1), 99-107, 2012 | 14 | 2012 |
| Understanding the role of nACE2 in neurogenic hypertension among COVID-19 patients PG Kulkarni, A Sakharkar, T Banerjee Hypertension Research 45 (2), 254-269, 2022 | 13 | 2022 |
| An In silico scientific basis for LL-37 as a therapeutic and Vitamin D as preventive for Covid-19. KB Lokhande, T Banerjee, KV Swamy, M Deshpande | 12 | 2020 |
| Insulin signaling pathway protects neuronal cell lines by Sirt3 mediated IRS2 activation N Mishra, S Lata, P Deshmukh, K Kamat, A Surolia, T Banerjee Biofactors 44 (3), 224-236, 2018 | 11 | 2018 |
| Effect of substrate binding loop mutations on the structure, kinetics, and inhibition of enoyl acyl carrier protein reductase from plasmodium falciparum K Maity, T Banerjee, N Prabakaran, N Surolia, A Surolia, K Suguna IUBMB life 63 (1), 30-41, 2011 | 10 | 2011 |
| Nanotized curcumin‐benzothiophene conjugate: A potential combination for treatment of cerebral malaria A Ghosh, T Banerjee IUBMB life 72 (12), 2637-2650, 2020 | 7 | 2020 |
| Mitofusin-2: functional switch between mitochondrial function and neurodegeneration PG Kulkarni, VM Mohire, PK Bhaisa, MM Joshi, CM Puranik, ... Mitochondrion 69, 116-129, 2023 | 6 | 2023 |
| DNA methylation-mediated Mfn2 gene regulation in the brain: a role in brain trauma-induced mitochondrial dysfunction and memory deficits PG Kulkarni, N Balasubramanian, R Manjrekar, T Banerjee, A Sakharkar Cellular and Molecular Neurobiology 43 (7), 3479-3495, 2023 | 3 | 2023 |
| Benzothiophene carboxamide compounds, composition and applications thereof A Surolia, T Banerjee, N Surolia, N Kapoor US Patent App. 13/183,024, 2012 | 2 | 2012 |
| A decoy strategy to activate the immune system MS Deshpande, T Banerjee IUBMB life 73 (10), 1205-1209, 2021 | | 2021 |
Neha KapoorAssociate ProfessorVerified email at hindu.du.ac.in
